Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002012383-25-002498·Aquestive Therapeutics, Inc.
Schedule 13G ownership disclosure
Aquestive Therapeutics Inc
Common Stock · CUSIP: 03843E104
Event date: 2025-09-30
- Filing-level shares
- 6,426,343
- Percent of class
- 5.3%
- BlackRock, Inc.
Shares: 6,426,343 · Class: 5.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-002498
- Form type
- SCHEDULE 13G/A
- Filer
- Aquestive Therapeutics, Inc.
- CIK
- CIK 1398733
- Filed
- Oct 17, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership